The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was named:
"Metallothionein Isoform II
".
FunFam 1: Metallothionein
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 19 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Zinc ion binding GO:0008270
Interacting selectively and non-covalently with zinc (Zn) ions.
|
216 |
A0A091HXW1 (/ISS)
A0A091NGX0 (/ISS)
A0A091SFR1 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A4PBS8 (/ISS)
B5G2T6 (/ISS)
(206 more) |
Cadmium ion binding GO:0046870
Interacting selectively and non-covalently with cadmium (Cd) ions.
|
38 |
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
(28 more) |
Zinc ion binding GO:0008270
Interacting selectively and non-covalently with zinc (Zn) ions.
|
27 |
B6ID08 (/IDA)
B6ID08 (/IDA)
P02795 (/IDA)
P02795 (/IDA)
P02795 (/IDA)
P02795 (/IDA)
P02795 (/IDA)
P02795 (/IDA)
P02795 (/IDA)
P13640 (/IDA)
(17 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
21 |
P02795 (/IPI)
P02795 (/IPI)
P02795 (/IPI)
P02795 (/IPI)
P02795 (/IPI)
P02795 (/IPI)
P02795 (/IPI)
P04731 (/IPI)
P04733 (/IPI)
P13640 (/IPI)
(11 more) |
Copper ion binding GO:0005507
Interacting selectively and non-covalently with copper (Cu) ions.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Drug binding GO:0008144
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Protein kinase activator activity GO:0030295
Binds to and increases the activity of a protein kinase, an enzyme which phosphorylates a protein.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Cysteine-type endopeptidase inhibitor activity involved in apoptotic process GO:0043027
Stops, prevents or reduces the activity of a cysteine-type endopeptidase involved in the apoptotic process.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Drug binding GO:0008144
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
|
10 | P02795 (/IDA) P02795 (/IDA) P02795 (/IDA) P02795 (/IDA) P02795 (/IDA) P02795 (/IDA) P02795 (/IDA) P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Cadmium ion binding GO:0046870
Interacting selectively and non-covalently with cadmium (Cd) ions.
|
10 | B6ID08 (/IDA) B6ID08 (/IDA) P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) P68503 (/IDA) P68503 (/IDA) P68503 (/IDA) P68503 (/IDA) P68503 (/IDA) |
Metal ion binding GO:0046872
Interacting selectively and non-covalently with any metal ion.
|
6 | P02802 (/IDA) P28184 (/IDA) P28184 (/IDA) P47945 (/IDA) P47945 (/IDA) P47945 (/IDA) |
Copper ion binding GO:0005507
Interacting selectively and non-covalently with copper (Cu) ions.
|
5 | P02802 (/IDA) P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) P37361 (/IDA) |
Metal ion binding GO:0046872
Interacting selectively and non-covalently with any metal ion.
|
4 | P80297 (/TAS) P80297 (/TAS) P80297 (/TAS) P80297 (/TAS) |
Copper ion binding GO:0005507
Interacting selectively and non-covalently with copper (Cu) ions.
|
3 | P25713 (/TAS) P25713 (/TAS) P25713 (/TAS) |
Antioxidant activity GO:0016209
Inhibition of the reactions brought about by dioxygen (O2) or peroxides. Usually the antioxidant is effective because it can itself be more easily oxidized than the substance protected. The term is often applied to components that can trap free radicals, thereby breaking the chain reaction that normally leads to extensive biological damage.
|
3 | P25713 (/NAS) P25713 (/NAS) P25713 (/NAS) |
Protein kinase activator activity GO:0030295
Binds to and increases the activity of a protein kinase, an enzyme which phosphorylates a protein.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Cysteine-type endopeptidase inhibitor activity involved in apoptotic process GO:0043027
Stops, prevents or reduces the activity of a cysteine-type endopeptidase involved in the apoptotic process.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Zinc ion binding GO:0008270
Interacting selectively and non-covalently with zinc (Zn) ions.
|
2 | P28184 (/IC) P28184 (/IC) |
Zinc ion binding GO:0008270
Interacting selectively and non-covalently with zinc (Zn) ions.
|
2 | P02798 (/TAS) P02802 (/TAS) |
There are 154 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Negative regulation of growth GO:0045926
Any process that stops, prevents or reduces the rate or extent of growth, the increase in size or mass of all or part of an organism.
|
137 |
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
(127 more) |
Cellular response to zinc ion GO:0071294
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.
|
107 |
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
(97 more) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
43 |
A0A091HXW1 (/ISS)
A0A091NGX0 (/ISS)
A0A091SFR1 (/ISS)
A4PBS8 (/ISS)
B5G2T6 (/ISS)
B5G2T6 (/ISS)
B5G2T6 (/ISS)
B5G2T6 (/ISS)
G3KFK4 (/ISS)
G3KFK4 (/ISS)
(33 more) |
Response to copper ion GO:0046688
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus.
|
34 |
A0RZE1 (/ISS)
A0RZE2 (/ISS)
A0RZE3 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE5 (/ISS)
A0RZE6 (/ISS)
(24 more) |
Cellular response to zinc ion GO:0071294
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.
|
30 |
P02795 (/IEP)
P02795 (/IEP)
P02795 (/IEP)
P02795 (/IEP)
P02795 (/IEP)
P02795 (/IEP)
P02795 (/IEP)
P04731 (/IEP)
P04732 (/IEP)
P04732 (/IEP)
(20 more) |
Cellular response to cadmium ion GO:0071276
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
|
22 |
P04731 (/IEP)
P04732 (/IEP)
P04732 (/IEP)
P04732 (/IEP)
P04732 (/IEP)
P04732 (/IEP)
P04732 (/IEP)
P04732 (/IEP)
P04732 (/IEP)
P04732 (/IEP)
(12 more) |
Response to zinc ion GO:0010043
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.
|
20 |
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
(10 more) |
Response to cadmium ion GO:0046686
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
|
20 |
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
(10 more) |
Response to mercury ion GO:0046689
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mercury ion stimulus.
|
20 |
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
(10 more) |
Protein complex oligomerization GO:0051259
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers; protein oligomers may be composed of different or identical monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
20 |
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
P68504 (/ISS)
(10 more) |
Energy reserve metabolic process GO:0006112
The chemical reactions and pathways by which a cell derives energy from stored compounds such as fats or glycogen.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Cholesterol catabolic process GO:0006707
The chemical reactions and pathways resulting in the breakdown of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Zinc ion transport GO:0006829
The directed movement of zinc (Zn II) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Cellular zinc ion homeostasis GO:0006882
Any process involved in the maintenance of an internal steady state of zinc ions at the level of a cell.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Negative regulation of autophagy GO:0010507
Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Positive regulation of cell death GO:0010942
Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Astrocyte development GO:0014002
The process aimed at the progression of an astrocyte over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. An astrocyte is the most abundant type of glial cell. Astrocytes provide support for neurons and regulate the environment in which they function.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Regulation of response to food GO:0032095
Any process that modulates the frequency, rate or extent of a response to a food stimulus.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Leptin-mediated signaling pathway GO:0033210
A series of molecular signals initiated by the binding of leptin to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Positive regulation of catalytic activity GO:0043085
Any process that activates or increases the activity of an enzyme.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Cellular lipid catabolic process GO:0044242
The chemical reactions and pathways resulting in the breakdown of lipids, as carried out by individual cells.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Regulation of protein glycosylation GO:0060049
Any process that modulates the frequency, rate or extent of protein glycosylation. Protein glycosylation is the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid, e.g. the addition of glycan chains to proteins.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Negative regulation of necrotic cell death GO:0060547
Any process that decreases the rate, frequency or extent of necrotic cell death. Necrotic cell death is a cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Positive regulation of lysosomal membrane permeability GO:0097214
Any process that increases the frequency, rate or extent of the passage or uptake of molecules by the lysosomal membrane.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Positive regulation of oxygen metabolic process GO:2000376
Any process that activates or increases the frequency, rate or extent of oxygen metabolic process.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Positive regulation of necrotic cell death GO:0010940
Any process that increases the rate, frequency or extent of necrotic cell death. Necrotic cell death is a cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Histone modification GO:0016570
The covalent alteration of one or more amino acid residues within a histone protein.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Removal of superoxide radicals GO:0019430
Any process, acting at the cellular level, involved in removing superoxide radicals (O2-) from a cell or organism, e.g. by conversion to dioxygen (O2) and hydrogen peroxide (H2O2).
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Negative regulation of axon extension GO:0030517
Any process that stops, prevents, or reduces the frequency, rate or extent of axon outgrowth.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Positive regulation of vascular endothelial growth factor receptor signaling pathway GO:0030949
Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Activation of protein kinase B activity GO:0032148
Any process that initiates the activity of the inactive enzyme protein kinase B.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Cellular response to drug GO:0035690
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress GO:0036091
Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is under oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043154
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Protein kinase B signaling GO:0043491
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Negative regulation of oxidoreductase activity GO:0051354
Any process that stops or reduces the rate of oxidoreductase activity, the catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Zinc ion homeostasis GO:0055069
Any process involved in the maintenance of an internal steady state of zinc ions within an organism or cell.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
ERK1 and ERK2 cascade GO:0070371
An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade may involve 4 different kinases, as it can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Cellular response to cadmium ion GO:0071276
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Cellular response to nitric oxide GO:0071732
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitric oxide stimulus.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Negative regulation of cysteine-type endopeptidase activity GO:2000117
Any process that stops, prevents, or reduces the frequency, rate or extent of cysteine-type endopeptidase activity.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Negative regulation of reactive oxygen species metabolic process GO:2000378
Any process that stops, prevents or reduces the frequency, rate or extent of reactive oxygen species metabolic process.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Response to zinc ion GO:0010043
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.
|
16 |
M4TBX9 (/IDA)
M4TQU4 (/IDA)
P52722 (/IDA)
P68501 (/IDA)
P68501 (/IDA)
P68501 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
(6 more) |
Cellular response to oxidative stress GO:0034599
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
16 |
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
Q2PFZ0 (/ISS)
(6 more) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
16 |
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
Q2PFZ0 (/ISS)
(6 more) |
Response to copper ion GO:0046688
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus.
|
16 |
M4TBX9 (/IDA)
M4TQU4 (/IDA)
P52722 (/IDA)
P68501 (/IDA)
P68501 (/IDA)
P68501 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
(6 more) |
Cadmium ion homeostasis GO:0055073
Any process involved in the maintenance of an internal steady state of cadmium ions within an organism or cell.
|
16 |
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
Q2PFZ0 (/ISS)
(6 more) |
Response to metal ion GO:0010038
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metal ion stimulus.
|
15 |
P02795 (/TAS)
P02795 (/TAS)
P02795 (/TAS)
P02795 (/TAS)
P02795 (/TAS)
P02795 (/TAS)
P02795 (/TAS)
P04731 (/TAS)
P25713 (/TAS)
P25713 (/TAS)
(5 more) |
Response to cadmium ion GO:0046686
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
|
13 |
M4TBX9 (/IDA)
M4TQU4 (/IDA)
P68501 (/IDA)
P68501 (/IDA)
P68501 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
(3 more) |
Response to mercury ion GO:0046689
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mercury ion stimulus.
|
13 |
M4TBX9 (/IDA)
M4TQU4 (/IDA)
P68501 (/IDA)
P68501 (/IDA)
P68501 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
(3 more) |
Response to interleukin-1 GO:0070555
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
|
12 |
P68497 (/IDA)
P68497 (/IDA)
P68497 (/IDA)
P68497 (/IDA)
P68497 (/IDA)
P68497 (/IDA)
P68498 (/IDA)
P68498 (/IDA)
P68498 (/IDA)
P68498 (/IDA)
(2 more) |
Cellular response to erythropoietin GO:0036018
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an erythropoietin stimulus.
|
11 |
P02795 (/IEP)
P02795 (/IEP)
P02795 (/IEP)
P02795 (/IEP)
P02795 (/IEP)
P02795 (/IEP)
P02795 (/IEP)
P80297 (/IEP)
P80297 (/IEP)
P80297 (/IEP)
(1 more) |
Cellular response to drug GO:0035690
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
10 | P02795 (/IDA) P02795 (/IDA) P02795 (/IDA) P02795 (/IDA) P02795 (/IDA) P02795 (/IDA) P02795 (/IDA) P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Cellular copper ion homeostasis GO:0006878
Any process involved in the maintenance of an internal steady state of copper ions at the level of a cell.
|
7 | P02795 (/TAS) P02795 (/TAS) P02795 (/TAS) P02795 (/TAS) P02795 (/TAS) P02795 (/TAS) P02795 (/TAS) |
Cellular response to interleukin-3 GO:0036016
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-3 stimulus.
|
7 | P02795 (/IEP) P02795 (/IEP) P02795 (/IEP) P02795 (/IEP) P02795 (/IEP) P02795 (/IEP) P02795 (/IEP) |
Interferon-gamma-mediated signaling pathway GO:0060333
A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far.
|
7 | P02795 (/TAS) P02795 (/TAS) P02795 (/TAS) P02795 (/TAS) P02795 (/TAS) P02795 (/TAS) P02795 (/TAS) |
Cellular metal ion homeostasis GO:0006875
Any process involved in the maintenance of an internal steady state of metal ions at the level of a cell.
|
6 | P02802 (/IDA) P28184 (/IDA) P28184 (/IDA) P47945 (/IDA) P47945 (/IDA) P47945 (/IDA) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
6 | P68498 (/IDA) P68498 (/IDA) P68498 (/IDA) P68498 (/IDA) P68498 (/IDA) P68498 (/IDA) |
Response to cadmium ion GO:0046686
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
|
5 | P02803 (/IEP) P02803 (/IEP) P52722 (/IEP) Q7ZSY6 (/IEP) Q7ZSY6 (/IEP) |
Protein complex oligomerization GO:0051259
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers; protein oligomers may be composed of different or identical monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
5 | P68503 (/IDA) P68503 (/IDA) P68503 (/IDA) P68503 (/IDA) P68503 (/IDA) |
Cellular zinc ion homeostasis GO:0006882
Any process involved in the maintenance of an internal steady state of zinc ions at the level of a cell.
|
4 | P02798 (/IMP) P02802 (/IMP) P28184 (/IMP) P28184 (/IMP) |
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
|
3 | P52722 (/IMP) Q7ZSY6 (/IMP) Q7ZSY6 (/IMP) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Cellular metal ion homeostasis GO:0006875
Any process involved in the maintenance of an internal steady state of metal ions at the level of a cell.
|
3 | P25713 (/NAS) P25713 (/NAS) P25713 (/NAS) |
Cellular metal ion homeostasis GO:0006875
Any process involved in the maintenance of an internal steady state of metal ions at the level of a cell.
|
3 | P25713 (/TAS) P25713 (/TAS) P25713 (/TAS) |
Response to metal ion GO:0010038
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metal ion stimulus.
|
3 | P52722 (/IDA) Q7ZSY6 (/IDA) Q7ZSY6 (/IDA) |
Positive regulation of vascular endothelial growth factor production GO:0010575
Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.
|
3 | P52722 (/IMP) Q7ZSY6 (/IMP) Q7ZSY6 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Positive regulation of necrotic cell death GO:0010940
Any process that increases the rate, frequency or extent of necrotic cell death. Necrotic cell death is a cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Positive regulation of cell death GO:0010942
Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Negative regulation of neuron projection development GO:0010977
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
3 | P25713 (/TAS) P25713 (/TAS) P25713 (/TAS) |
Histone modification GO:0016570
The covalent alteration of one or more amino acid residues within a histone protein.
|
3 | P25713 (/IMP) P25713 (/IMP) P25713 (/IMP) |
Removal of superoxide radicals GO:0019430
Any process, acting at the cellular level, involved in removing superoxide radicals (O2-) from a cell or organism, e.g. by conversion to dioxygen (O2) and hydrogen peroxide (H2O2).
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
3 | P25713 (/IMP) P25713 (/IMP) P25713 (/IMP) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
3 | P25713 (/TAS) P25713 (/TAS) P25713 (/TAS) |
Negative regulation of axon extension GO:0030517
Any process that stops, prevents, or reduces the frequency, rate or extent of axon outgrowth.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Positive regulation of vascular endothelial growth factor receptor signaling pathway GO:0030949
Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Activation of protein kinase B activity GO:0032148
Any process that initiates the activity of the inactive enzyme protein kinase B.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Cellular response to oxidative stress GO:0034599
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
3 | P25713 (/IEP) P25713 (/IEP) P25713 (/IEP) |
Positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress GO:0036091
Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is under oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043154
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Protein kinase B signaling GO:0043491
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
3 | P02802 (/IDA) P28184 (/IDA) P28184 (/IDA) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Response to cadmium ion GO:0046686
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
|
3 | P47945 (/ISO) P47945 (/ISO) P47945 (/ISO) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Negative regulation of oxidoreductase activity GO:0051354
Any process that stops or reduces the rate of oxidoreductase activity, the catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Response to methylmercury GO:0051597
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methylmercury stimulus.
|
3 | P52722 (/IDA) Q7ZSY6 (/IDA) Q7ZSY6 (/IDA) |
Zinc ion homeostasis GO:0055069
Any process involved in the maintenance of an internal steady state of zinc ions within an organism or cell.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Cadmium ion homeostasis GO:0055073
Any process involved in the maintenance of an internal steady state of cadmium ions within an organism or cell.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Negative regulation of necrotic cell death GO:0060547
Any process that decreases the rate, frequency or extent of necrotic cell death. Necrotic cell death is a cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
ERK1 and ERK2 cascade GO:0070371
An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade may involve 4 different kinases, as it can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Cellular response to cadmium ion GO:0071276
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Cellular response to hypoxia GO:0071456
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
3 | P25713 (/IEP) P25713 (/IEP) P25713 (/IEP) |
Cellular response to nitric oxide GO:0071732
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitric oxide stimulus.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Positive regulation of cell migration involved in sprouting angiogenesis GO:0090050
Any process that increases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
|
3 | P52722 (/IMP) Q7ZSY6 (/IMP) Q7ZSY6 (/IMP) |
Negative regulation of cysteine-type endopeptidase activity GO:2000117
Any process that stops, prevents, or reduces the frequency, rate or extent of cysteine-type endopeptidase activity.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Negative regulation of reactive oxygen species metabolic process GO:2000378
Any process that stops, prevents or reduces the frequency, rate or extent of reactive oxygen species metabolic process.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Energy reserve metabolic process GO:0006112
The chemical reactions and pathways by which a cell derives energy from stored compounds such as fats or glycogen.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Cholesterol catabolic process GO:0006707
The chemical reactions and pathways resulting in the breakdown of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Zinc ion transport GO:0006829
The directed movement of zinc (Zn II) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
2 | P28184 (/IDA) P28184 (/IDA) |
Cellular zinc ion homeostasis GO:0006882
Any process involved in the maintenance of an internal steady state of zinc ions at the level of a cell.
|
2 | P28184 (/IDA) P28184 (/IDA) |
Response to oxidative stress GO:0006979
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Nitric oxide mediated signal transduction GO:0007263
Any intracellular signal transduction in which the signal is passed on within the cell via nitric oxide (NO). Includes synthesis of nitric oxide, receptors/sensors for nitric oxide (such as soluble guanylyl cyclase/sGC) and downstream effectors that further transmit the signal within the cell. Nitric oxide transmits its downstream effects through either cyclic GMP (cGMP)-dependent or independent mechanisms.
|
2 | P02798 (/IMP) P02802 (/IMP) |
Response to zinc ion GO:0010043
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.
|
2 | P02803 (/IEP) P02803 (/IEP) |
Negative regulation of autophagy GO:0010507
Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Positive regulation of cell death GO:0010942
Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Astrocyte development GO:0014002
The process aimed at the progression of an astrocyte over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. An astrocyte is the most abundant type of glial cell. Astrocytes provide support for neurons and regulate the environment in which they function.
|
2 | P28184 (/IDA) P28184 (/IDA) |
Regulation of response to food GO:0032095
Any process that modulates the frequency, rate or extent of a response to a food stimulus.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Leptin-mediated signaling pathway GO:0033210
A series of molecular signals initiated by the binding of leptin to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Cellular response to oxidative stress GO:0034599
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
2 | P28184 (/IDA) P28184 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Positive regulation of catalytic activity GO:0043085
Any process that activates or increases the activity of an enzyme.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Cellular lipid catabolic process GO:0044242
The chemical reactions and pathways resulting in the breakdown of lipids, as carried out by individual cells.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Astrocyte activation GO:0048143
A change in morphology and behavior of an astrocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
2 | B6ID08 (/IEP) B6ID08 (/IEP) |
Negative regulation of neurogenesis GO:0050768
Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the generation of cells within the nervous system.
|
2 | P28184 (/IDA) P28184 (/IDA) |
Cadmium ion homeostasis GO:0055073
Any process involved in the maintenance of an internal steady state of cadmium ions within an organism or cell.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Regulation of protein glycosylation GO:0060049
Any process that modulates the frequency, rate or extent of protein glycosylation. Protein glycosylation is the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid, e.g. the addition of glycan chains to proteins.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Negative regulation of necrotic cell death GO:0060547
Any process that decreases the rate, frequency or extent of necrotic cell death. Necrotic cell death is a cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Cellular response to zinc ion GO:0071294
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.
|
2 | P02802 (/IDA) P13640 (/IDA) |
Positive regulation of lysosomal membrane permeability GO:0097214
Any process that increases the frequency, rate or extent of the passage or uptake of molecules by the lysosomal membrane.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Positive regulation of oxygen metabolic process GO:2000376
Any process that activates or increases the frequency, rate or extent of oxygen metabolic process.
|
2 | P28184 (/IMP) P28184 (/IMP) |
Brain development GO:0007420
The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
|
1 | P37361 (/IEP) |
Response to bacterium GO:0009617
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium.
|
1 | P02798 (/IEP) |
Detoxification of copper ion GO:0010273
Any process that reduces or removes the toxicity of copper ion. These include transport of copper away from sensitive areas and to compartments or complexes whose purpose is sequestration of copper ion.
|
1 | P02802 (/IGI) |
Detoxification of copper ion GO:0010273
Any process that reduces or removes the toxicity of copper ion. These include transport of copper away from sensitive areas and to compartments or complexes whose purpose is sequestration of copper ion.
|
1 | P02798 (/IMP) |
Monocyte differentiation GO:0030224
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a monocyte.
|
1 | P13640 (/NAS) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
1 | P37361 (/NAS) |
Cellular response to vascular endothelial growth factor stimulus GO:0035924
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
|
1 | P13640 (/IEP) |
Monocyte activation GO:0042117
The change in morphology and behavior of a monocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
1 | P13640 (/NAS) |
Negative regulation of growth GO:0045926
Any process that stops, prevents or reduces the rate or extent of growth, the increase in size or mass of all or part of an organism.
|
1 | P13640 (/IDA) |
Negative regulation of neurogenesis GO:0050768
Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the generation of cells within the nervous system.
|
1 | P37361 (/NAS) |
Negative regulation of dendrite morphogenesis GO:0050774
Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite morphogenesis.
|
1 | P37361 (/NAS) |
Cellular response to chromate GO:0071247
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chromate stimulus.
|
1 | P02802 (/IDA) |
Cellular response to copper ion GO:0071280
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus.
|
1 | P13640 (/IEP) |
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
|
1 | P37361 (/IDA) |
Negative regulation of hydrogen peroxide catabolic process GO:2000296
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide catabolic process.
|
1 | P37361 (/IDA) |
There are 26 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
155 |
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
(145 more) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
139 |
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
(129 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
121 |
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
F7ECS1 (/ISS)
(111 more) |
Cell GO:0005623
The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.
|
34 |
A0RZE1 (/ISS)
A0RZE2 (/ISS)
A0RZE3 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE4 (/ISS)
A0RZE5 (/ISS)
A0RZE6 (/ISS)
(24 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
20 |
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
(10 more) |
Synaptic vesicle GO:0008021
A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane.
|
19 |
P25713 (/ISS)
P25713 (/ISS)
P25713 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
(9 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
18 |
P02795 (/TAS)
P02795 (/TAS)
P02795 (/TAS)
P02795 (/TAS)
P02795 (/TAS)
P02795 (/TAS)
P02795 (/TAS)
P02798 (/TAS)
P02802 (/TAS)
P04731 (/TAS)
(8 more) |
Inclusion body GO:0016234
A discrete intracellular part formed of aggregated molecules such as proteins or other biopolymers.
|
18 |
P28184 (/ISS)
P28184 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37359 (/ISS)
P37360 (/ISS)
P37361 (/ISS)
P55944 (/ISS)
Q2MJS5 (/ISS)
Q2MJS5 (/ISS)
(8 more) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
17 |
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
P04732 (/IDA)
(7 more) |
Cell GO:0005623
The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.
|
13 |
M4TBX9 (/IDA)
M4TQU4 (/IDA)
P68501 (/IDA)
P68501 (/IDA)
P68501 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
P68503 (/IDA)
(3 more) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
4 | P13640 (/IDA) P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Synaptic vesicle GO:0008021
A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane.
|
3 | P28184 (/IDA) P28184 (/IDA) P37361 (/IDA) |
Inclusion body GO:0016234
A discrete intracellular part formed of aggregated molecules such as proteins or other biopolymers.
|
3 | P25713 (/IDA) P25713 (/IDA) P25713 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | P37361 (/IDA) |
Mitochondrial outer membrane GO:0005741
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
|
1 | P37361 (/IDA) |
Lysosome GO:0005764
A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
|
1 | P02802 (/IDA) |
Rough endoplasmic reticulum GO:0005791
The rough (or granular) endoplasmic reticulum (ER) has ribosomes adhering to the outer surface; the ribosomes are the site of translation of the mRNA for those proteins which are either to be retained within the cisternae (ER-resident proteins), the proteins of the lysosomes, or the proteins destined for export from the cell. Glycoproteins undergo their initial glycosylation within the cisternae.
|
1 | P37361 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
1 | P02802 (/IDA) |
Ribosome GO:0005840
An intracellular organelle, about 200 A in diameter, consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits, one large and one small, each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients, expressed in Svedberg units (symbol: S). Hence, the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit, while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins.
|
1 | P37361 (/IDA) |
Microtubule GO:0005874
Any of the long, generally straight, hollow tubes of internal diameter 12-15 nm and external diameter 24 nm found in a wide variety of eukaryotic cells; each consists (usually) of 13 protofilaments of polymeric tubulin, staggered in such a manner that the tubulin monomers are arranged in a helical pattern on the microtubular surface, and with the alpha/beta axes of the tubulin subunits parallel to the long axis of the tubule; exist in equilibrium with pool of tubulin monomers and can be rapidly assembled or disassembled in response to physiological stimuli; concerned with force generation, e.g. in the spindle.
|
1 | P37361 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
1 | P37361 (/IDA) |
Postsynaptic density GO:0014069
An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
|
1 | P37361 (/IDA) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
1 | P37361 (/IDA) |
Dendritic spine GO:0043197
A small, membranous protrusion from a dendrite that forms a postsynaptic compartment - typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable including \thin\, \stubby\, \mushroom\, and \branched\, with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity.
|
1 | P37361 (/IDA) |
Astrocyte projection GO:0097449
A prolongation or process extending from the soma of an astrocyte and wrapping around neurons.
|
1 | P37361 (/IDA) |
Astrocyte end-foot GO:0097450
Terminal process of astrocyte abutting non-neuronal surfaces in the brain.
|
1 | P37361 (/IDA) |